Showing posts with label Schizophrenia. Show all posts
Showing posts with label Schizophrenia. Show all posts

May 23, 2014

Friday, May 23, 2014
According to researchers at Oxford University, mental illness has an effect on life expectancy that is equivalent or greater than smoking. A great deal of effort and spending has been invested into smoking cessation programs and smoking awareness campaigns. This new research should prompt the government, health care and social services to shift their focus in an effort to increase life expectancy for those living with mental illness.

Researchers reviewed 20 review papers from clinical studies that reported mortality risk among mental health problems, substance and alcohol abuse, dementia, autistic spectrum disorders, learning disability and childhood behavioral disorders. These studies included over 1.7 million individuals and over 250,000 deaths. They also used studies and reviews that reported life expectancy and risk of dying by suicide. All results were compared to data for heavy smoking.

According to their findings, “one in four people in the UK will experience some kind of mental health problem in the course of a year” while smokers consist of roughly 21% of British men and 19% of women. 

They discovered that all diagnoses studied had an increased mortality risk similar or greater than heavy smoking. Some of the estimated reductions in life expectancy were found to be as follows:
  • Bipolar Disorder: 9 - 20 years
  • Schizophrenia: 10 – 20 years
  • Drug and Alcohol Abuse: 9 - 24 years
  • Recurrent Depression: 7 - 11 years
  • Heavy smoking: 8 - 10 years
Dr. Seena Fazel of the Department of Psychiatry at Oxford University said: "We found that many mental health diagnoses are associated with a drop in life expectancy as great as that associated with smoking 20 or more cigarettes a day."
Despite the fact that this study did not mention the prevalence of smoking among persons with mental illness, the results are still devastating.

There may be many reasons for this phenomenon. For example:
  • Psychiatric patients and those with drug and/or alcohol dependence can be more likely to engage in high-risk behaviours.
  • Physical health problems may not be taken seriously and treated properly due to the stigma attached to their mental illness.
  • Many mental illnesses can create physical health problems and/or worsen pre-existing ones.
  • People with serious mental illness may not access healthcare effectively.
  • The de-medicalization of mental illness may increase the likelihood that physical health problems go untreated or neglected.
Life expectancy may increase if only we could make mental health a priority as we have with smoking. In addition to funding and advancing research on mental illness, we should improve health and social services to ensure that persons with mental illness have better access to health care, suitable employment and supports in their community.

Many mental illnesses reduce life expectancy more than heavy smoking

© www.mentalhealthblog.com

January 19, 2013

Saturday, January 19, 2013

Research shows that the use of choline supplements during pregnancy may prevent schizophrenia.  Specifically, lower rates of physiological schizophrenic risk factors in infants 33 days old has been noted when the dietary supplement is given during the second and third trimesters of pregnancy and early infancy.

Robert Freedman, MD, professor and chairman of the Department of Psychiatry, University of Colorado School of Medicine and one of the study's authors states: "Basic research indicates that choline supplementation during pregnancy facilitates cognitive functioning in offspring. Our finding that it ameliorates some of the pathophysiology associated with risk for schizophrenia now requires longer-term follow-up to assess whether it decreases risk for the later development of illness as well."

Choline is a water-soluble essential nutrient, typically grouped within the B-complex vitamins. It can be found naturally in foods such as liver, muscle meats, fish, nuts and eggs.  According to the American Institute of Medicine, pregnant women require between 450 and 3500 milligrams of choline each day and 550 to 3500 milligrams while lactating.  Infants aged 0-6 months need a minimum daily dose of 125 milligrams of choline and 150 milligrams from 7-12 months of age.

“Choline is also being studied for potential benefits in liver disease, including chronic hepatitis and cirrhosis, depression, memory loss, Alzheimer's disease and dementia, and certain types of seizures.”

To test their theory, researchers observed infant responses to a clicking sound.  Typically, the brain responds fully to an initial click, however the response to a second click immediately following the first is inhibited.  This trait is often absent among schizophrenia patients and relates to poor sensory filtering and familial transmission of schizophrenia risk.  Researchers observed this effect among infants to represent the illness as schizophrenia does not normally appear until adolescence.

“Half the healthy pregnant women in this study took 3,600 milligrams of phosphatidylcholine each morning and 2,700 milligrams each evening; the other half took placebo. After delivery, their infants received 100 milligrams of phosphatidylcholine per day or placebo. Eighty-six percent of infants exposed to pre- and postnatal choline supplementation, compared to 43% of unexposed infants, inhibited the response to repeated sounds, as measured with EEG sensors placed on the baby's head during sleep.”

These results could not only assist in early detection of schizophrenia, but may even help in preventing the illness or developing more effective treatments.

Some examples of choline found in different food sources:

Type of Food
mg of choline
5 ounces (142 g) raw beef liver
473
Large hardboiled egg
113
Half a pound (227 g) cod fish
190
Half a pound of chicken
150
Quart of milk, 1% fat
173
A gram soy lecithin
30
100 grams of Soybeans dry
116
A pound (454 grams) of cauliflower
177
A pound of spinach
113
A cup of wheat germ
202
Two cups (0.47 liters) firm tofu
142
Two cups of cooked kidney beans
108
A cup of uncooked quinoa
119
A cup of uncooked amaranth
135
A grapefruit
19
Three cups (710 cc) cooked brown rice
54
A cup (146 g) of peanuts
77
A cup (143 g) of almonds
74

Choline Supplementation DuringPregnancy Presents a New Approach to Schizophrenia Prevention
Choline

July 23, 2011

Saturday, July 23, 2011
In recent news, scientists have uncovered the molecular pathway involved in the onset of schizophrenia as well as a potential new treatment for the illness. By observing the effects of a cancer drug called MS-275 in mice, researchers discovered that symptoms of schizophrenia were successfully alleviated.

Schizophrenia is a mental disorder characterized by disintegration of thought processes and emotional responsiveness. It is most commonly manifested as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking. The onset of symptoms typically occurs in young adulthood. Schizophrenia is accompanied by significant social or occupational dysfunction.

Additionally, the disease is said to be caused by a combination of genetic and environmental factors. Those with a diagnosis of schizophrenia have changes in both brain structure and chemistry. Studies using neuropsychological tests and brain imaging technologies such as fMRI and PET to examine functional differences in brain activity have shown that differences seem to most commonly occur in the frontal lobes, hippocampus and temporal lobes.

The greatest risk for developing schizophrenia is having a first-degree relative with the disease. Environmental factors associated with the development of schizophrenia include the living environment, drug use and prenatal stressors. Factors such as hypoxia and infection, or stress and malnutrition in the mother during fetal development, may result in a slight increase in the risk of schizophrenia later in life. A number of drugs have been associated with the development of schizophrenia including cannabis, cocaine and amphetamines.
“According to the World Health Organization, 90% of people with untreated schizophrenia are in developing countries. Current treatments for schizophrenia include both psychological treatments such as psychotherapy, counselling or cognitive behaviour therapy and/or medication. However, many of the antipsychotic drugs or major tranquillisers used to treat or manage the illness have very bad side-effects.”
Schizophrenia is said to affect about 24 million people worldwide.

Medications prescribed to treat schizophrenia include:
    • Chlorpromazine (Thorazine)
    • Haloperidol (Haldol)
    • Perphenazine (generic only)
    • Fluphenazine (generic only)
    • clozapine (Clozaril)
    • Risperidone (Risperdal)
    • Olanzapine (Zyprexa)
    • Quetiapine (Seroquel)
    • Ziprasidone (Geodon)
    • Aripiprazole (Abilify)
    • Aliperidone (Invega)
Typical side effects include:
    • Drowsiness
    • Dizziness when changing positions
    • Blurred vision
    • Rapid heartbeat
    • Sensitivity to the sun
    • Skin rashes
    • Menstrual problems for women
    • Rigidity
    • Persistent muscle spasms
    • Tremors
    • Restlessness
Professor Peter Giese at King's College London discovered that individuals with schizophrenia had a reduction in the enzyme activator called p35. By manipulating the level of this enzyme in mice, the researchers were able to mirror typical cognitive impairments found in those with schizophrenia. Consequently, human post-mortem brains revealed that schizophrenic patients had approximately 50% less p35 in their brains.

That being said, the brain requires, among other things, the activation of a protein call Cdk5 to assist in proper development and this protein can only be activated in the presence of the p35 enzyme.

Therefore, by manipulating the level of p35 enzyme in mice, researchers noted that “the mice showed a reduction in synaptic proteins -- important in maintaining neural connections -- and displayed symptoms associated with schizophrenia, including learning impairments and inability to react to sensory stimuli.”

Subsequently, Professor Giese and his research team noticed that the reduction of the p35 enzyme altered molecules in the brain that are targeted by the cancer drug MS-275. To their delight, the molecular changes were corrected and the schizophrenic symptoms were alleviated by this drug.

With any luck, more research will prove that this drug is more beneficial than current medications with intolerable side-effects.

Cancer Drugs May Help Treatment of Schizophrenia
Schizophrenia
Mental Health Medications

© www.mentalhealthblog.com

August 24, 2008

Sunday, August 24, 2008

"New research supports a growing body of literature that attributes maternal exposure to severe stress during the early months of pregnancy to an increased susceptibility to schizophrenia in the offspring". - source

The researchers, Dolores Malaspina, Anita Steckler, and Joseph Steckler are referring to extreme stressors such as that experienced during natural disasters, terrorist attacks, war, sudden death etc.

The discovery came about after reviewing a collection of data gathered from 88,829 people born in Jerusalem between the years 1964 to 1976. A correlation existed among a higher risk of developing schizophrenia among the offspring of mothers who were in their second month of pregnancy during the Arab-Israeli "Six Day War". In addition, the correlation was even greater among females. In fact, females were 4.3 times more likely to develop schizophrenia, as opposed to males who were merely 1.2 times more likely to develop the disorder.

The theory is that stress hormones are amplified during such times of great distress and the placenta is very sensitivity to these hormones.

This research does not provide proof or a causal link, but it does support the existing research that suggests similar results. Malaspina makes sure to note that some exposure to maternal stress hormones are necessary, but extreme stress should be addressed in order to avoid any sort of impact on the fetus.

© www.mentalhealthblog.com

April 13, 2008

Sunday, April 13, 2008
The British Journal of Psychiatry presented a study conducted by Yale School of Medicine regarding the tendency to extract a meaningful message from meaningless noise. The study implies that, over time, this ability could produce a 'matrix of unreality' that triggers the initial psychotic phase of schizophrenia-spectrum disorders. The study implies that this ability could be an early sign of schizophrenia.

The study consisted of a measly 43 participants who had already been diagnosed with prodromal symptoms such as social withdrawal, mild perceptual alterations or misinterpretation of social cues.

A medication called olanzapine was used in this study. It is also known as zyprexa, an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Participants were assessed for up to two years after being randomly assigned to either this medication or a placebo.

The participants listened to a reading of a text through headphones, but this text was read by six different people at the same time. The overlap of the words made comprehension virtually impossible. The only words detected with any kind of consistency were increase, children, A-OK, and Republican.

"Eighty percent of the participants who 'heard' phrases of four or more words in length went on to develop a schizophrenia-related illness during times that they were not taking olanzapine, said the lead author, Ralph Hoffman, M.D., associate professor of psychiatry. In contrast, only six percent of those in the study converted to schizophrenia-related illness if the phrases 'heard' were less than three words in length." – Article

Clearly this is not sufficient research to conclusively report the effectiveness of this type of screening tool, but it’s an interesting attempt. How long could it be until we are using simple white noise to render a diagnosis.



Detect anything meaningful?

© www.mentalhealthblog.com

February 8, 2008

Friday, February 08, 2008
There already exists much evidence of low birth weights and pre-maturity among newborns of mothers that suffer stressful life events during pregnancy. "Chemicals released by the mother’s brain in response to stress may have an effect on the fetus’ developing brain. These effects may be strongest in early pregnancy, when protective barriers between the mother and fetus are not fully constructed."

Schizophrenia is believed to commence during early brain development; however environmental factors during a pregnancy may influence the risk of developing schizophrenia.

A study conducted by Ali S. Khashan of the University of Manchester suggests a likelihood of developing schizophrenia when a child’s mother experiences a stressful event during the first trimester of pregnancy.

The subjects in this study consisted of 1.38 million Danish births occurring between 1973 and 1995. A national registry was used to verify relatives of the mothers that either passed away or received a diagnosis of cancer, heart attack or stroke during the course of their pregnancy. Khashan found that during their pregnancies, the mothers of 21,987 children were exposed to the death of a relative, mothers of 14, 206 children were exposed to a relative receiving a diagnosis of cancer, heart attack or stroke, and most striking, 7,331 children observed had eventually developed schizophrenia.

Results illustrated a 67% greater risk of developing schizophrenia or other disorders when exposed to the death of a relative during the first trimester. Six months prior to pregnancy or any other time during the pregnancy held no significance in the development of schizophrenia. As well, the significance appeared only in those without a family history of mental illness.

Although, the study only assesses risk and is not suggesting any concrete findings, it would have been more informative to have knowledge the schizophrenics’ age at the end of the study in order to rule out any possible association with societal changes or social upheavals. Also, research on a more global perspective would certainly have supported the validity of the study. Overall however, this does provide a decent starting point for future research.

Article

© www.mentalhealthblog.com

Popular Posts

Dentalget.com is dental equipment supplier, we provide high quality dental instruments, dental handpiece at a discount price. Free shipping worldwide.

Categories

9/11 AADD Abortion Academic Success Acetylcholine ADD Adderall Addiction ADHD Adult Attention Deficit Disorder Adultery Advertising Aggression Aging Agreeableness AIDS Air Pressure Alcohol Alcohol Abuse Alcohol Dependence Alcoholism alpha-CaM kinase II Altitude Alzheimer's Amphetamine Amygdala Amyloid Amyloid Deposition Anesthesia Anger Anterior Cingulate Cortex Anterograde Amnesia Anti-Depressants Anti-Psychotic Anticholinergic Anticonvulsant Antiepileptic Antioxidants Anxiety Anxious-Avoidant Anxious-Preoccupied Apolipoprotein E Army Aromatherapy Asperger Syndrome Assessment Associative Learning Asthma Attachment Theory Attention Attention Deficit Disorder Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Autonomic Nervous System Average Sleep Requirements B-type Natriuretic Peptide Babies Balance Behavioral Problems Behaviour Behavioural Impairment Behavioural Therapy Benadryl Bipolar Disorder Blood Clot Blood Pressure Blue Light Blue Light Goggles Body Mass Index Bone Marrow Brain Brain Development Brain Imaging Brain Injury Brain Stem Brain Surgery Breast Cancer Buddhism bullying Bupropion Business C-reactive Protein Calories CAMH Canada Canadian Charter of Rights and Freedoms Cancer Carbohydrates Cardiovascular Disease Care Facilities Caregiver cars Cdk5 Cell Phone Central Nervous System Centre for Addiction and Mental Health Cerebellum Cerebral Amyloid Angiopathy Cerebral Cortex Cerebrospinal Fluid Cerebrovascular Accident Cerebrovascular Insult Chat Rooms Chewing Childhood Disabilities Childhood Disintegrative Disorder Childhood Emotional Neglect Children Chitin Chitosan Cholesterol Choline Chromosome Chronic Pain Syndrome Chronic Stress Circadian Rhythm Cirrhosis Citalopram Classical Conditioning Climate Change Clot-Busting Drug Co-morbidity Cocaine Cognition Cognitive Development Cognitive Impairment Colloquially Brain Attack Coma Communication Device Communication Technology Concentration Concerta Concussion Conflict Confusion Conscientiousness Control Group Coordination Correlation Cortisol Counselling Couples CPAP Crack CRASH-2 CRASH-3 Creativity Criminal Code Cyberbullying Cyberpsychology Cyklokapron Daytrana Death Death Toll Decision-Making Declarative Memory Deep Brain Stimulation Delusion Dementia Dentures Depression Destrostat Deviant Behaviour Dexedrine Dextromethorphan Diabetes Diet Dietary Supplements Diphenhydramine Disability discrimination Dismissive-Avoidant Disorganized Attachment Disorganized Speech Disorientation Dizziness Docosahexaenoic Acid (DHA) Double-Blind Dream Drinking Drowsiness Drug Abuse Drug Dependence Drug Use Drugs DSM DSM-5 Dual Diagnosis Early Onset Alzheimer's Economic Crisis Ecstasy Effexor Ego Eicosapentaenoic Acid (EPA) Elderly Electrical Stimulation Electroconvulsive Therapy Electrodes Email Embitterment Embolic Emotion Emotional Neglect Emotional Problems Emotional Well-Being Employee Enrivonment Enzyme Epilepsy Estrogen Ethics Evolution Experimental Group Extracellular Signal-Regulated Kinase (ERK) Extroversion Facebook Facebook Fan Page Facebook Friends Family Family Therapy Fast Food Father Father Absenteeism Fatherhood FDA Fear Fearful-Avoidant FeelingBetterNow Fetus Fibrin Fish Oil fluoxetine fMRI Focalin Focus Food Fraud Friday Gamma Secretase Genetic Disorders Genetics Ginkgo Biloba Glucose Glutamate Receptor God Gout Guest Blogger Hair Pulling Haiti Hallucination Hallucinogenic Halo Effect Harm-Reduction Headache Healthy Eating Hearing Heart Attack Heart Disease Hematopoietic Stem Cells Hepatitis Hepatitis C Herbal Supplements Hereditary Angioedema Heredity Heroin High Blood Pressure Hippocampus Hockey Homelessness Hormone Housing Hox Genes Hoxb8 Cells Human Rights Hydromorphone Hyper-social Networker Hyperactivity Hypothalamus Illness Impulse Control Impulsivity Inattentiveness Infant Infidelity Inflammation Insecure Attachment Insomnia Instant Messaging Insulin Intellectual Development Intellectual Disability Internet Intracranial Bleeding Introversion Introvert Ischemic Stroke KASPAR Ketamine Ketogenic Kleptomania Laptop Latent Inhibition Learning Learning Disability Leukotrienes Limbic System Lithium Liver Locked-In Syndrome Long Term Memory Long-Term Potentiation Longevity Lupus Lysteda Maestro Rechargeable System Major Depression Mania MAOI Marriage MDMA Medication Meditation Melatonin Memory Memory Loss Memory Task Men Mental Health Mental Health Forum Mental Heath Mental Illness Metadate Metyrapone Mice Microglia Mild Cognitive Impairment (MCI) Mild Traumatic Brain Injury Military Mind-Body Mindless Eating Mitochondria MOHLTC Mood Disorder Morphine Mortality Rates MRI MS-275 Multiple Sclerosis Muscle Weakness music therapy Narcissism Natasha Richardson National Sleep Foundation Natural Disaster Nature/Nurture Nausea Necrosis Neglect Nerve Neuro-imaging Neurobiology Neurodegeneration Neurodegenrative Diseases Neurodevelopment Disorders Neurogenesis Neurological Disease Neuromarketing Neuron Neuropathy Neuroticism Neurotransmitter News Nintendo Wii Non-REM Sleep Nose Nurse Ratched Nutrition Obesity Obessive Compulsive Spectrum Disorder (OCD) Offspring Olfactory Gland OM3 Emotional Balance Omega 3 Ontario Ontario Review Board Ontario Works Opioid Oral Health Organic Ottawa Over-activity Over-Medication Ovulation Oxidative Cell Oxygen Oxytocin p35 Pacemaker Pain Pain Killer Pain Management Pancreatic Polypeptide Pancreatitis Paralysis Paranoia Paraskevidekatriaphobia Parenthood Parents Parkinson's Paroxetine Paxil PDD-NOS perception Perfume Peripheral Nervous System Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Pathway personality traits Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) PET Scan Pharmacology Phobias Physical Health Physiological Plasmin Plasminogen Plasticity Platelet-Activating Factor Politics Post-Concussion Assessment and Cognitive Test (ImPACT) Potassium Ion Channel Poverty Pregnancy Pressure Procedural Memory Promiscuity Prozac PsychBoard.com Psychiatric Ward Psychological Psychological Inventories Psychologist Psychology Psychology Forum Psychology of Eating Psychosis PTED PTSD Public Health Pyromania Quadriplegic Rehab Relationships Reliability Religion REM Research Retigabine Retrograde Amnesia Rett Syndrome Risperdal Ritalin road rage Robot Robotics Rodent Research Rosiglitazone Samsung Satiety Scales Schizophrenia School Screening Secure Attachment Sedatives Seizure Self-Affirmation Intervention Self-Confidence Self-Esteem Self-Integrity Self-Worth Semantic Memory Senior Seroquel Serotonin Serzone Sex Sex Therapy Sexual Orientation Sexual Satisfaction Shock Therapy Sideline Concussion Assessment Test (SCAT2) Sleep Sleep Apnea Sleep Disorders Sleep Quality Sleep Stages Smartphone Smoking Snacking Sniffing Technology Social Assistance Social Deficits Social Isolation Social Media Social Network Social Rejection Social Skills Social Worker Socialization Societal Change Soft Palate Soldier Somatic Nervous System Spatial Memory Special K Speech Spinal Cord Spinal Cord Injury Spinal Tap Sports Injury SSRI Statin Stem Cell Stimulant Strattera Stress Stress Hormone Stroke Substance Abuse Sugar Suicide Superstition Support Survey Suspicious Tablet Talk Therapy Tamoxifen Tanorexia Tax Payer Technology Television Telomere Temperature Testosterone Texting Therapy Thorazine Threshold Thrombosis Thrombotic Tinnitus Tissue Plasminogen Activator Topographical Disorientation Tranexamic Acid Trauma Treatment Tremors Trial Tribunal Trichotillomania Type-2 Diabetes Vagus Nerve Validity Ventromedial Prefrontal Cortex Video Games Virtual Reality Vision Visual Attention Vitamin B Vitamins Vitiligo Voice Vyvanse Walnuts Weight Loss Welfare Wellbutrin Wernicke–Korsakoff syndrome Wet Brain White Blood Cells Women Work World Health Organization Zileuton Zyban Zyprexa µ-opiate receptors (MOR)